Comparison of long-term outcomes between everolimus-eluting and sirolimus-eluting stents in small vessels.

Authors

Hironori Kitabata, MedStar Washington Hospital Center
Joshua P. Loh, MedStar Washington Hospital Center
Gabriel L. Sardi, MedStar Washington Hospital Center
Salem Badr, MedStar Washington Hospital Center
Danny Dvir, MedStar Washington Hospital Center
Israel M. Barbash, MedStar Washington Hospital Center
Lakshmana K. Pendyala, MedStar Washington Hospital Center
Sa'ar Minha, MedStar Washington Hospital Center
Rebecca Torguson, MedStar Washington Hospital CenterFollow
Fang Chen, MedStar Washington Hospital Center
Lowell F. Satler, MedStar Washington Hospital CenterFollow
William O. Suddath, MedStar Washington Hospital Center
Kenneth M. Kent, MedStar Washington Hospital CenterFollow
Augusto D. Pichard, MedStar Washington Hospital Center
Ron Waksman, MedStar Washington Hospital Center

Document Type

Journal Article

Publication Date

4-1-2013

Journal

American Journal of Cardiology

Volume

Volume 111, Issue 7

Inclusive Pages

973-978

Keywords

Coronary Artery Disease--drug therapy; Drug-Eluting Stents; Immunosuppressive Agents--administration & dosage; Sirolimus--administration & dosage; Sirolimus--analogs & derivatives

APA Citation

Kitabata, H., Loh, J. P., Sardi, G. L., Badr, S., Dvir, D., Barbash, I. M., . . . Waksman, R. (2013). Comparison of long-term outcomes between everolimus-eluting and sirolimus-eluting stents in small vessels. American Journal of Cardiology, 111(7), 973-978.

Peer Reviewed

1